XELJANZ 5mg (tofacitinib) is a prescription drug called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.
Manufacturer : Pfizer Inc.
Strengths available : 5mg
Storage : Store at 20°C to 25°C
- XELJANZ/XELJANZ XR may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). The recommended dose of XELJANZ is 5 mg twice daily and the recommended dose of XELJANZ XR is 11 mg once daily.
- XELJANZ/XELJANZ XR is given orally with or without food.
- Swallow XELJANZ XR tablets whole and intact. Do not crush, split, or chew.
Common side effects are upper respiratory tract infections, headache, diarrhea, and cold symptoms such as sore throat, runny or stuffy nose. feeling very tired, yellow skin or eyes (jaundice), loss of appetite, vomiting, dark urine, clay-colored stool, skin rash, clay-colored stools, skin rash, fever or chills, night sweats, weight loss, changes in bowel habits, pain or burning when you urinate, sores in your mouth or throat, stabbing chest pain, shortness of breath, cough with mucus or blood, or skin redness or swelling.